English
Kopran Q2 Results
- BSE: 524280
- NSE: KOPRAN
- ISIN: INE082A01010
- Sector: Biotechnology & Drugs
BSE
157.95
-2.15 (-1.34%)
-2.15 (-1.34%)Volume8.84 K
Updated: Fri 7 Nov, 2025 | 15:42:27
NSE
158.46-1.96 (-1.22%)
-1.96 (-1.22%)Volume1.90 L
Updated: Fri 7 Nov, 2025 | 15:44:41
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Kopran Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 25 | QoQ Comp |
|---|---|---|---|
| Total Operating Expense | 140.68 | 125.34 | 12.41% |
| Depreciation/ Amortization | 3.85 | 4.26 | -0.49% |
| Operating Income | 10.88 | 9.87 | -23.83% |
| Net Income | 7.38 | 7.45 | -33.45% |
| Other Operating Expenses Total | 24.64 | 20.25 | 11.88% |
| Net Income Before Taxes | 9.64 | 9.89 | -34.54% |
| Total Revenue | 151.56 | 135.22 | 8.70% |
| Selling/ General/ Admin Expenses Total | 14.53 | 15.43 | 8.86% |
| Diluted Normalized EPS | 1.53 | 1.54 | -66.74% |